Reglagene’s technology is the product of 20 years of meticulous research from the labs of Professor Laurence Hurley at the University of Arizona. Professor Hurley discovered that unusual DNA structures called “quadruplexes,” found in many genes exploited by cancer and other diseases, are actually master controllers of gene expression. Sensing an opportunity to use this discovery for the benefit of patients, Professor Hurley pioneered Quadruplex Master Switch Technology (QMST) to enable the development of medicines that fight disease through the control of gene expression.